Valpharma Group has specialised for over 40 years in the development and contract manufacture of modified release products in capsules and tablets. With proprietary technology, the company supplies pharmaceutical products to clients worldwide. Valpharma’s Research and Development Department annually innovates numerous modified release formulations, optimising dosing schedules from multiple daily administrations to once or twice daily, enhancing therapeutic efficacy and minimising side effects. The company is authorised by several national authorities, including those of Italy, Brazil, Iran, Ivory Coast, Japan, Turkey, Taiwan, and the United Arab Emirates. Valpharma Group SpA is a leading European pharmaceutical entity in the development and contract manufacturing of oral solid dosage medicines and nutraceuticals, with extensive experience in commercial supply across more than 70 countries on five continents.

Services include:
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Forms
- Biologics
- Packaging
- Food Supplements
- Regulatory Services
- Solid Dosage

Valpharma Group continues to play a pivotal role in the pharmaceutical industry, offering a diverse array of services tailored to meet the evolving needs of its clients.